Dihydroartemisinin-piperaquine
Access
-
Approved
Eurartesim®
Alfasigma
3-day cure, artemisinin-based combination therapies (TPP-1)
Therapeutic indication |
|
Dosing |
|
Efficacy |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Project Director |
Adam Aspinall |